Boston Scientific anticipates $25M hit after FDA pulls women's health products

Boston Scientific said Wednesday is forecasting a $25 million hit to its 2019 revenue after the U.S. Food & Drug Administration yanked two of its product lines from the market.

Miach Orthopaedics adds two executives ahead of FDA submissions

Westborough biotech Miach Orthopaedics has added two senior executives with expertise in regulatory submissions and clinical trials as the company looks to bring its ACL repair technology to market.

Optim uses SBA award to land new customers

Optim is using its recent U.S. Small Business Administration award to grow its company and attract new customers.

Former Milford bottle manufacturing plant to become warehouse

The recent buyers of a vacant bottling plant in Milford have proposed a major renovation of the 322,000-square-foot facility.

ReWalk places first U.S. system covered by major insurer

ReWalk Robotics saw its stock skyrocket Tuesday as the company said it has sold its first personal exoskeleton device to a spinal cord injury patient via insurance firm Cigna Corp.

FDA orders Boston Scientific to stop selling women's health product

The U.S. Food and Drug Administration has ordered Marlborough medical device maker Boston Scientific and another manufacturer to immediately stop selling transvaginal surgical mesh products.

Cultivate begins Uxbridge negotiations for 130K sq. ft. marijuana facility

A week after starting talks with Leicester, marijuana retailer Cultivate has begun negotiations with Uxbridge for a cannabis cultivation and manufacturing facility of up to 130,000 square feet.

Arthrosurface creates pre-sized knee joint replacements

Franklin joint replacement manufacturer Arthrosurface has begun selling its newest device, the Patellofemoral WaveKahuna Arthroplasty System.